Through integration of data at the patient, cell, and protein structural levels, coupled with in vitro models, we show that KCNQ genes, specifically KCNQ1 and KCNQ3, and their protein products contribute to gastro-oesophageal cancer phenotype and are a potential therapeutic target. Here, KCNQ1 is linked to carcinoma of esophagus.